🇺🇸 FDA
Patent

US 12403192

Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease

granted A61KA61K2039/543A61K2039/545

Quick answer

US patent 12403192 (Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2039/543, A61K2039/545, A61K2039/55505, A61K2039/55511